肝门部胆管癌的围手术期处理

Perioperative management of hilar cholangiocarcinoma

胆管癌是来源于胆管上皮细胞的恶性肿瘤，其中以肝门部胆管癌最为常见，占胆管癌的58％一70％。由于肝门部胆管癌发病不典型，解剖部位特殊，根治性切除率低，复发率高，预后较差，5年存活率仅为14．7％～33．8％。因此肝门部胆管癌的早期诊断和根治性切除是提高疗效的最有效的方法，良好的围手术期处理，对于提高肝门部胆管癌根治性切除率以及改善患者的预后有积极的作用，本文就肝门部胆管癌的围手术期处理进行阐述。

Cholangiocarcinoma is a malignant tumor originating from bile duct epithelial cells, among which hilar cholangiocarcinoma is the most common, accounting for about 58%-70% of cholangiocarcinoma. Due to its atypical clinical features, special anatomical site, low radical resection rate, high recurrence rate and poor prognosis, the 5-year survival rate of hilar cholangiocarcinoma was only 14.7%-33. 8%. Hence, the most effective method of hilar cholangiocarcinoma lies in early diagnosis and radical resection. Good perioperative management can improve the rate of radical resection of hilar cholangiocarcinoma and contribute a lot to prognosis of the patients. The perioperative management of hilar cholangiocarcinoma is described as follows.